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Abstract
Isoprene, the 2-methyl analog of 1,3-butadiene, is ubiquitous in the environment, with major
contributions to total isoprene emissions stemming from natural processes despite the compound
being a bulk industrial chemical. Additionally, isoprene is a combustion product and a major
component in cigarette smoke. Isoprene has been classified as possibly carcinogenic to humans
(group 2B) by IARC and as reasonably anticipated to be a human carcinogen by the National
Toxicology Program. Isoprene, like butadiene, requires metabolic activation to reactive epoxides
to exhibit its carcinogenic properties. The mode of action has been postulated to be that of a
genotoxic carcinogen, with formation of promutagenic DNA adducts being essential for
mutagenesis and carcinogenesis. In rodents, isoprene-induced tumors show unique point mutations
(A→T transversions) in the K-ras protooncogene at codon 61. Therefore, we investigated adducts
formed after reaction of 2′-deoxyadenosine (dAdo1) with the two monoepoxides of isoprene, 2-
ethenyl-2-methyloxirane (IP-1,2-O) and propen-2-yloxirane (IP-3,4-O), under physiological
conditions. The formation of N1–2′-deoxyinosine (N1-dIno) due to deamination of N1-dAdo
adducts was of particular interest, since N1-dIno adducts are suspected to have high mutagenic
1Abbreviations: dAdo, 2′-deoxyadenosine; dIno, 2′-deoxyinosine; dR, deoxyribose; ESI-MS, positive ion electrospray mass
spectrometry; IP-1,2-O, isoprene-1,2-oxide (2-ethenyl-2-methyloxirane); IP-3,4-O, isoprene-3,4-oxide (propen-2-yloxirane);
IPOcommercial, commercially available 95 % isoprene-1,2-oxide with 5 % isoprene-3,4-oxide; MS/MS, tandem mass spectrometry.
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potential based on in vitro experiments. Major stable adducts were identified by HPLC, UV-
Spectrometry and LC-MS/MS and characterized by 1H and 1H,13C HSQC and NMR experiments.
Adducts of IP-1,2-O that were fully identified are: R,S-C1-N6-dAdo, R-C2-N6-dAdo, and S-C2-
N6-dAdo; adducts of IP-3,4-O are: S-C3-N6-dAdo, R-C3-N6-dAdo, R,S-C4-N6-dAdo, S-C4-N1-
dIno, R-C4-N1-dIno, R-C3-N1-dIno, S-C3-N1-dIno, and C3-N7-Ade. Both monoepoxides formed
adducts on the external and internal oxirane carbons. This is the first study to describe adducts of
isoprene monoepoxides with dAdo. Characterization of adducts formed by isoprene monoepoxides
with deoxynucleosides and subsequently with DNA represent the first step toward evaluating their
potential for being converted into a mutation, or as biomarkers of isoprene metabolism and
exposure.
INTRODUCTION
Isoprene, the 2-methyl analog of 1,3-butadiene, is an industrial chemical that has been
classified as possibly carcinogenic to humans (group 2B) by IARC and as reasonably
anticipated to be a human carcinogen by the National Toxicology Program. These
conclusions are based on sufficient evidence from animal data (1–3), although to date,
adequate epidemiological studies have not been available for categorization as a human
carcinogen. Based on its abundance in cigarette smoke and its animal carcinogenicity, the
World Health Organization has recently ranked isoprene third after 1,3-butadiene and
acetaldehyde and similar to 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK, one of
the major tobacco-specific nitrosamines) with respect to cancer hazard stemming from
smoking (4).
Like butadiene, isoprene is ubiquitous in the environment, with ambient air concentrations
generally less than 10 ppb (0.030 mg/m3) (3). The main sources of anthropogenic release of
isoprene into the atmosphere are combustion processes (5–8).
In industry, isoprene is used as a monomer in the manufacture of synthetic rubber (cis-
polyisoprene) and elastomers (copolymers with styrene or isobutene) (3). Occupational
exposures to isoprene in the U.S. are usually less than 1 ppm (3 mg/m3) as 8 h-time
weighted average (9;10).
A significant contribution to total isoprene emissions stems from natural sources, since
isoprene is a side product of several biological processes in plants, animals and bacteria
(11;12). Human exposure to isoprene is largely due to its generation during endogenous
processes, particularly isoprenoid biosynthesis, as it is the major hydrocarbon exhaled by
humans (13). In summary, isoprene emissions from natural sources exceed those from
industrial output by approximately 300-fold. Nevertheless, smoking increases isoprene
exposure significantly and environmental tobacco smoke is the primary source of isoprene
in indoor air (3;14).
Isoprene has been demonstrated to cause tumors in multiple organs in rodents, with mice
being more sensitive than rats (15–18). Harderian gland and lung neoplasias developed in
male mice after inhalation exposure to isoprene, and were linked to unique point mutations
(A→T transversions) in the K-ras protooncogene at codon 61 (19;20).
Similar to its structural relative butadiene, isoprene is metabolized via oxidation by the
cytochrome P450 enzymes, primarily CYP2E1, to the monoepoxides 2-ethenyl-2-
methyloxirane (IP-1,2-O) and propen-2-yloxirane (IP-3,4-O). These can be further oxidized
to the diepoxide (2-methylbioxirane) (21–23). The epoxides are hydrolyzed by epoxide
hydrolase to the corresponding diol or epoxydiol isomers, or conjugated by glutathione-S-
transferase (21–25).
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Epoxides are reactive alkylating agents at nucleophilic sites of cellular macromolecules,
including proteins and DNA. Formation of DNA adducts is believed to be the causal link
between chemical exposures and mutagenesis and carcinogenesis (26;27). Chemical-specific
DNA adducts are well established biomarkers for internal exposure and metabolism (28).
Unlike isoprene diepoxide, which was demonstrated to be mutagenic in vitro in Salmonella
typhimurium strain TA100, neither the isoprene monoepoxides, nor the parent isoprene with
or without metabolic activation were mutagenic in any Salmonella strains tested (15;29;30).
However, with metabolic activation, IP-1,2-O and isoprene induced DNA strand breaks in
human cells in vitro in the comet assay (31), thus demonstrating genotoxic potential.
To date, adduct formation of isoprene monoepoxides has been investigated in only a limited
number of studies. This may be in part due to the negative outcome in the in vitro
mutagenicity tests. Additionally, IP-1,2-O, thought to be the predominant metabolite based
on in vitro studies in rodent liver microsomes (23;32), is rapidly hydrolyzed in aqueous
solution, thus probably preventing formation of adducts at biologically relevant levels. The
half-lives of the monoepoxides in Tris-HCl buffer at physiological pH and temperature
differ significantly: 1.25 hrs for IP-1,2-O compared to 73 hrs for IP-3,4-O (29). Bleasdale et
al. (33) investigated the reactivity of IP-1,2-O with different nucleophiles in vitro. In vivo,
adducts of both monoepoxides on the N-terminal valine of hemoglobin were detected in rats
and mice following intraperitoneal administration of isoprene itself or a commercially
available isoprene monoepoxide mixture, containing 95% IP-1,2-O and 5% IP-3,4-O (34).
To date, the only studies investigating adducts of isoprene epoxides with DNA have been
conducted by our group. In our previous in vitro study we demonstrated the formation of
N7-guanine adducts after incubation of the 2′-deoxynucleotide or calf thymus DNA with
isoprene monoepoxides (35).
In the present study, we investigated the generation of adducts from the reaction of the
isoprene monoepoxides with 2′-deoxyadenosine (dAdo) (Scheme 1 and 2). Under
physiological conditions, the major sites of adduct formation by alkyl epoxides on DNA
bases are expected to be the endocyclic purine nitrogens, e.g. N3 and N1 of adenine, via an
SN2 mechanism. For epoxides with a vinyl or aryl substituent, such as styrene oxide and
butadiene monoepoxide, direct adduct formation on exocyclic amino groups has also been
reported (as reviewed in 36). In reactions of DNA with styrene and butadiene monoepoxides
in vitro, N1-dAdo adducts have been identified, and evidence of their formation in vivo in
humans was reported based on 32P-postlabeling detection (37–39). N1-dAdo adducts tend to
rearrange to N6-dAdo adducts or to deaminate to the corresponding N1-deoxyinosine (dIno)
adducts (38;40). We had a particular interest in the latter, because N1-dIno adducts of
butadiene monoepoxide were demonstrated to be highly mutagenic in site-directed
mutagenesis studies in vitro (41;42).
EXPERIMENTAL PROCEDURES
Caution
Epoxides are suspect carcinogens and should be handled with care
Chemicals
IP-1,2-O (2-ethenyl-2-methyloxirane, 2-methyl-2-vinyloxirane) was purchased from Aldrich
Chemical Co. (Milwaukee, WI) as a 95:5 mixture with IP-3,4-O and will be referred to as
IPOcommercial (34). IP-1,2-O (> 99.8 %) was obtained through purification of IPOcommercial
by preparative GC on a Varian series 2700 gas chromatograph (Varian Instrument Division,
Palo Alto, CA) equipped with a thermal conductivity detector. The column used was 2.5 m
× 4 mm i.d., 10 % polyethylene glycol 20 M (Applied Science Laboratories Inc., State
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College, PA); nitrogen was the carrier gas with a flow rate of 50 mL/min, the injection
temperature was 20ºC, using a temperature gradient program starting at 20ºC, increasing
8°C/min to 150°C (tR: 2.26 min) (Cottrell et al., personal communication). IP-3,4-O (> 99
%) was synthesized and purified according to Harwood et al. (43).
The pure S-enantiomers of IP-1,2-O and IP-3,4-O were prepared as described (32). 2′-
Deoxyadenosine (dAdo) and 2′-deoxyinosine (dIno) were purchased from Sigma Chemical
Co. (St. Louis, MO). HPLC grade acetonitrile was purchased from Mallinckrodt Baker, Inc.
(Paris, KY).
NMR Spectrometry
1H NMR spectra were recorded at 500 MHz on a Varian INOVA 500 spectrometer (Palo
Alto, CA) using 1–2 mg of the purified, lyophilized adducts dissolved in DMSO-d6.
Chemical shifts are reported in ppm relative to TMS. Heteronuclear Single Quantum
Coherence (HSQC) and Heteronuclear Multiple Bond Correlation (HMBC) NMR
experiments were performed on the Varian INOVA 500 spectrometer with 13C signals
acquired at 125 MHz. 1H and 13C signal assignments were made on the basis of
Heteronuclear Single Quantum Coherence (HSQC) and Heteronuclear Multiple Bond
Correlation (HMBC) NMR experiments.
HPLC analysis and purification
HPLC separations and purification were performed on reversed-phase (C18) Aquasil
columns (Thermo Scientific, Raleigh, NC), using an Agilent Technologies (Palo Alto, CA)
1100 series quaternary pump, and a Hewlett Packard (Avondale, PA) 1040A diode-array
detector (DAD) with HP Chem Station Software (Rev. A.05.04). Chromatograms were
recorded with detector wavelengths set at 265 nm (between λmax of the N1-dIno adducts
(250 nm) and N6-dAdo adducts (270 nm) and at 235 nm (to record the co-elution of
byproducts). Additionally, UV spectra of HPLC peaks were recorded between 190 – 400 nm
in 2 nm steps to confirm adduct identity. Mobile phases were: Mobile phase A, 17 mM
ammonium acetate buffer (pH 5.5) containing 1.5% acetonitrile; mobile phase B, 17 mM
ammonium acetate buffer (pH 5.5) containing 30% acetonitrile. Analytical separations were
performed by injection of 80–100 μL of the reaction mixtures onto a 4.6 × 250 mm, 5 μm,
100 Å C18 Aquasil column with a flow of 1 mL/min. The linear gradient program was: 0–1
min 0% B, 1–60 min to 37% B, 60–80 min to 50% B (gradient program 1). Semipreparative
separations were performed by injection of 0.5–1 mL amounts of the reaction mixtures onto
a 10 × 250 mm, 5 μm, 100 Å C18 Aquasil column with a flow of 4 mL/min. The linear
gradient program was: 0–1 min 0% B, 1–60 min to 37% B, 60–70 min to 45% B, 70–80 min
45% B (gradient program 2).
Liquid Chromatography-Electrospray Ionization-Mass Spectrometry (LC-ESI-MS)
LC-ESI-MS analyses were performed on an LCQDECA quadrupole ion trap mass
spectrometer (Thermo Finnigan, San Jose, CA) equipped with an API2 electrospray
ionization source operating in the positive ion mode. The heated transfer capillary
temperature was kept at 350ºC. Nitrogen was used as both sheath and auxiliary gases and
maintained at 80 and 20 arbitrary units, respectively. Spray voltage was 4.5 kV; collision
energy was 20 eV. Reaction mixtures (10 μL) were analyzed by on-line LC-ESI-MS to
acquire full scan ESI spectra. Online LC separations were carried out as described above for
analytical HPLC conditions. A post-column split of the LC flow was accomplished using a
T-connector to allow only about 1/3 (350 μL/min) of the LC effluent into the ESI source.
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General Methods. 1. Reaction of dAdo or dIno with IP-1,2-O and IP-3,4-O
Solutions of dAdo or dIno were prepared by dissolving 20 μmol of the deoxynucleoside in 1
mL 50 mM phosphate buffer (pH 7.4). Aliquots of the solutions (200 μL) were transferred to
glass vials with screw-top Teflon-coated caps and incubated with a 10-fold molar excess (4
μL) of either IP-1,2-O, S-IP-1,2-O, IP-3,4-O or S-IP-3,4-O in an Orbit environmental shaker
(Lab-Line Instruments, Inc., Melrose Park, IL) at 37ºC for 24 h. The reaction mixtures were
diluted 5-fold to 1 mL with doubly distilled water and extracted 3 times with equal volumes
of diethyl ether to remove excess isoprene monoepoxide. Residual ether was evaporated
from the reaction mixture under a stream of nitrogen at room temperature.
Under the analytical HPLC/LC conditions described above (4.6 × 250 mm C18 Aquasil
column gradient program 1), reaction of dAdo with IP-1,2-O yielded several major products
(Figure 1a), three of which were identified: dAdo-1 (68.7 min, 2 partially resolved peaks),
dAdo-2 (73.4 min) and dAdo-3 (74.5 min) (Table 1).
Under the same conditions, separation of the mixture from the reaction of dAdo with IP-3,4-
O (Figure 2a) yielded the major products: dAdo-6 (66.0 min), dAdo-7 (69.2 min) and
dAdo-8 (71.6 min) along with five minor products: Ade-1 (42.9 min), dIno-2 (46.7 min),
dIno-3 (47.7 min), dIno-4 (49.0 min), and dIno-5 (50.7 min) (Table 1).
Mild acid hydrolysis—The deglycosylation of the dAdo and dIno adducts was performed
at 80ºC for 1 h in 0.1 M HCl by adding an appropriate amount of 1 M HCl to the reaction
mixture. The hydrolysates were neutralized with 2 M KOH.
Synthesis of dAdo and dIno Adducts of Isoprene Monoepoxides
dAdo was dissolved in 50 mM phosphate buffer (pH 7.4) (40 μmol/mL) by shaking at 37ºC
for 1 h.
Either IP-1,2-O or IP-3,4-O in a 9-fold molar excess was added to the dAdo solution and the
mixture was incubated in an Orbit environmental shaker at 37ºC for 3 days. The reaction
mixture was either frozen or extracted immediately 3 times with 3 volumes of diethyl ether
to remove excess isoprene monoepoxides and residual ether was evaporated from the
reaction mixture under a nitrogen stream at room temperature. The reaction mixture was
filtered through 0.2 μm Uniflo syringe filters (Schleicher & Schuell, Keene, NH) before
separation by semi-preparative HPLC.
The fractions containing the major adducts were collected and dried in a Savant SVC100
Speed Vac (Thermo Savant, Milford, MA), and dissolved in a small amount of doubly
distilled water. Fractions containing identical adducts were combined, lyophilized and
characterized by NMR.
dAdo-1—1H NMR (500 MHz, DMSO-d6) 8.36, s, 1H, H8; 8.21, bs, 1H, H2; 7.16, bs, 1H,
N6H; partially resolved 6.35, dd, J = 7.7, 6.2 Hz, H1′ and 6.34, ψt. J = 7.0 Hz, H1′, total 1H;
5.93, dd, 1H, J=17.3, 10.7 Hz, H3IP; 5.30, bd, 1H, J=3.1 Hz, 3′-OH; 5.24, dd, 1H, J=17.3,
1.9 Hz, C=CH2IP; 5.19, dd, 1H, J=11.5, 6.1 Hz, 5′-OH; 4.98, dd, 1H, J=10.7, 1.9 Hz,
C=CH2IP; 4.41, m, 1H, H3′; 3.87, m, 1H, H4′; 3.62, dt, 1H, J=4.4, 11.4 Hz, H5′ or H5″;
3.57, bs, 1H, CH2IP; 3.55 – 3.49, m, 1H, H5″ or H5′; 2.73, m, 1H, H2″; 2.26, ddd, 1H,
J=13.2, 7.0, 2.9 Hz, H2′; 1.18, s, 3H, CH3IP ppm. 13C NMR (125 MHz, DMSO-d6) 152.3,
C2; 148.2, C4; 144.0, C3IP; 139.6, 1JC-H=214.5 Hz, C8; 119.6, C5; 112.6, C=CH2IP; 88.0,
C4′; 83.9, 1JC-H=163.5 Hz, C1′; 72.4, C2IP; 71.0, C3′; 62.1, C5′; 49.4, CH2IP; 39.6, C2′;
25.6, CH3IP ppm.
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dAdo-2—1H NMR (500 MHz, DMSO-d6) 8.36, s, 1H, H8; 8.19, s, 1H, H2; 6.78, s, 1H,
N6H; 6.34, dd, 1H, J= 7.6, 6.2 Hz, H1′; 6.10, dd, 1H, J= 17.6, 10.8 Hz, H3IP; 5.38, bt, 1H,
J=6.0 Hz, 1-OHIP; 5.30, d, 1H, J=3.5 Hz, 3′-OH; 5.16, t, 1H, J=5.6 Hz, 5′-OH; 5.07, dd,
J=17.6, 1.1 Hz, C=CH2IP; 5.05, dd, 1H, J=10.8, 1.1 Hz, C=CH2IP; 4.41, m, 1H, H3′; 3.88,
m, 1H, H4′; 3.66 – 3.59, m, 2H, H5′ or H5″ and CH2IP; 3.54 – 3.48, m, 2H, H5″ or H5′ and
CH2IP; 2.74, ddd, 1H, J=13.3, 7.6, 5.7 Hz, H2″; 2.26, ddd, 1H, 13.3, 6.2, 2.9 Hz, H2′; 1.55,
s, 3H, CH3IP ppm. 13C NMR (125 MHz, DMSO-d6) 154.2, C6; 151.7, 1JC-H=200.5 Hz, C2;
148.0, C4; 141.8, 1JC-H=156.0 Hz, C3IP; 139.6, 1 JC-H=214.0 Hz, C8; 120.3, C5; 113.2,
C=CH2IP; 87.9, C4′; 84.0, 1JC-H=158.0 Hz, C1′; 71.0, C3′; 67.5, CH2IP; 61.9, C5′; 58.9,
C2IP; 39.5, C2′; 21.6, 1JC-H=127.5 Hz, CH3IP ppm.
dAdo-3—1H NMR (500 MHz, DMSO-d6) 8.36, s, 1H, H8; 8.19, s, 1H, H2; 6.78, s, 1H,
N6H; 6.34, dd, 1H, J= 7.6, 6.3 Hz, H1′; 6.10, dd, 1H, J= 17.6, 10.8 Hz, H3IP; 5.39, bs, 1H 1-
OHIP; 5.32, bs, 1H, 3′-OH; 5.16, bt, 1H, J=~5 Hz, 5′-OH; 5.07, dd, J=17.6, 1.2 Hz,
C=CH2IP; 5.05, dd, 1H, J=10.8, 1.2 Hz, C=CH2IP; 4.41, m, 1H, H3′; 3.88, m, 1H, H4′; 3.66
– 3.59, m, 2H, H5′ or H5″ and CH2IP; 3.54 – 3.48, m, 2H, H5″ or H5′ and CH2IP; 2.74, ddd,
1H, J=13.2, 7.6, 5.7 Hz, H2″; 2.26, ddd, 1H, 13.2, 6.3, 2.8 Hz, H2′; 1.54, s, 3H, CH3IP
ppm. 13C NMR (125 MHz, DMSO-d6) 154.2, C6; 151.7, 1JC-H=200.5 Hz, C2; 148.0, C4;
141.8, 1JC-H=156.0 Hz, C3IP; 139.6, 1JC-H=214.0 Hz, C8; 120.3, C5; 113.2, C=CH2IP; 87.9,
C4′; 84.0, 1JC-H=158.0 Hz, C1′; 71.0, C3′; 67.5, CH2IP; 61.9, C5′; 58.9, C2IP; 39.5, C2′;
21.6, 1JC-H=127.5 Hz, CH3IP ppm.
dAdo-6—1H NMR (500 MHz, DMSO-d6) 8.35, s, 1H, H8; 8.18, s, 1H, H2; 7.54, d, 1H, J
= 8.5 Hz, N6H; 6.35, dd, 1H, J = 7.6, 6.2 Hz, H1′;5.31, d, J = 3.6 Hz, 1H 3′-OH; 5.21, t,
1H, J = 5.7 Hz, 5′-OH; 4.90, s, 1H, C=CH2IP; 4.80, m, 1H, H2IP; 4.79, s, 1H, C=CH2IP;
4.74, bs, 1H, 1-OHIP; 4.41, m, 1H, H3′; 3.88, m, 1H, H4′; 3.64, m, 2H, CH2IP; 3.62, m, 1H,
H5′ or H5″; 3.51, m, 1H, H5″ or H5′; 2.73, ddd, 1H, J = 13.0, 7.6, 5.9 Hz, H2″; 2.26 (ddd, J
= 13.06, 6.2, 2.8 Hz, 1H, H2′; 1.76, s, 3H, CH3IP ppm. 13C NMR (125 MHz, DMSO-d6)
154.2, C6; 152.2, C2; 148.3, C4; 143.9, C3IP; 139.3, 1JC-H=212.0 Hz, C8; 119.7, C5; 111.2,
C=CH2IP; 88.2, C4′; 83.8, C1′; 70.9, C3′; 57.0, C2IP; 20.1, CH3IP ppm
dAdo-7—1H NMR (500 MHz, DMSO-d6) 8.36, s,1H, H8; 8.18, s, 1H, H2; 7.54, d, 1H,
JNH-H3i = 8.4 Hz, N6H; 6.35, dd, 1H, J=7.4, 6.2 Hz, H1′; 5.30, d, 1H, J=4.0 Hz, 3′-OH;
5.20, dd, 1H, J=6.4, 5.1 Hz, 5′-OH; 4.89, s, 1H, C=CH2IP; 4.80, m, + 4.79, s, 2H, H2IP +
C=CH2IP, overlapping; 4.74, bs, 1H, 1-OHIP; 4.41, m, 1H, H3′; 3.88, m, 1H, IP H4′; 3.64,
m, 2H, CH2IP; 3.61, m, 1H, and 3.52, m, 1H, H5′, H5″; 2.72, ddd, 1H, J=13.2, 7.4, 6.0 Hz,
H2″; 2.26, ddd, 13.2, 6.2, 2.8 Hz, 1H, H2′; 1.76, s, 3H, CH3IP ppm. 13C NMR (125 MHz,
DMSO-d6) 153.6, C6; 151.8, 1JC-H=196.0 Hz, C2; 147.3, C4; 143.8, C3IP;
139.1, 1JC-H=212.0 Hz, C8; 118.9, C5; 111.1, C=CH2IP; 87.8, C4′; 84.1, C1′; 70.8, C3′;
61.5, CH2IP; 61.4, C5′; 56.6, C2IP; 19.8, 1JC-H=125.5 Hz, CH3IP ppm.
dAdo-8—1H NMR (500 MHz, DMSO-d6) 8.34, s, 1H, H8; 8.21, s, 1H, H2; 7.44, bs, 1H,
N6H; 6.34, dd, 1H, J = 7.6, 6.3 Hz, H1′; 5.32, bs, 1H, 3′-OH; 5.21, bs, 1H, 5′-OH; 4.90, bs,
1H, C=CH2IP; 4.77, bs, 1H, C=CH2IP; 4.41, td, 1H J = 5.4, 2.8, 2.6 Hz, H3′; 4.20 bt, 1H, J
= 5.4, Hz, H2IP; 3.88 m, 1H, H4′; 3.62, dd, 1H, J = 11.8, 4.2 Hz, and 3.52, dd, 1H, J = 11.8,
4.2 Hz, H5′, H5″; 3.65, bs, 1H, CH2IP; 3.46, bs, 1H, CH2IP; 3.33, bs, 1H, 2-OHIP; 2.72, ddd,
1H, J = 13.2, 7.6, 6.0 Hz, H2″; 2.26, ddd, 1H, J = 13.2, 6.3, 2.9 Hz, H2′; 1.72, s, 3H, CH3IP
ppm. 13C (125 MHz, DMSO-d6) 153.9, C6; 152.0, 1JC-H=199.5 Hz, C2; 148.0, C4; 146.3,
C3IP; 139.3, 1JC-H=219.0 Hz, C8; 119.5, C5; 111.0, C=CH2IP; 87.6, C4′; 83.5, C1′; 72.6,
C2IP; 70.6, C3′; 61.5, C5′; 44.3, CH2IP; 39.6, C2′; 17.7, CH3IP ppm.
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dIno-2—1H (500 MHz, DMSO-d6) 8.31, s 1H, H8; 8.25, s, 1H, H2; 6.30, dd, 1H, J = 7.2,
6.5 Hz, H1′; 5.33, dd, 1H, J = 7.5, 4.5 Hz, 3′-OH; 4.99, t, 1H, J = 5.4 Hz, 5′-OH; 4.91, s,
1H, C=CH2IP; 4.84, s, 1H, C=CH2IP; 4.39, m, 1H, H3′; 4.24 dd, 1H, J = 13.1, 3.9 Hz,
CH2IP; 4.17, m, 1H, H2IP; 3.86, dt, 1H, J = 4.6, 3.1 Hz, H4′; 3.76, dd, 1H, J = 13.1, 8.4 Hz,
CH2IP; 3.59, td, 1H, J = 11.35, 4.6 Hz, H5′ or H5″; 3.54–3.49, m, 1H, H5″ or H5′; 2.62, ddd,
1H, J = 13.3, 7.2, 6.11 Hz, H2″; 2.30, ddd, 1H, J = 13.3, 6.5, 3.3 Hz, H2′; 1.78, s, 3H,
CH3IP ppm. 13C (125 MHz, DMSO-d6) 156.0, C6; 149.2, 1JC-H=208.0 Hz, C2; 147.1, C4;
145.4, C3IP; 138.9, 1JC-H=215.0 Hz, C8; 123.7, C5; 111.5, C=CH2IP; 88.0, C4′; 83.5, C1′;
71.3, C2IP; 70.6, C3′; 61.7, C5′; 49.9, CH2IP; 39.7, C2′; 18.2, CH3IP ppm
dIno-5—1H (500 MHz, DMSO-d6) 8.33, s, 1H, H8; 8.23, s, 1H, H2; 6.31, 1H, t, J = 6.8,
Hz, H1′; 5.36, m, 1H, H2IP; 5.11, bs, 1H, 3′-OH; 5.07, m, 1H, C=CH2IP; 4.98, m 1H, 5′-OH;
4.92. m, 1H, C=CH2IP; 4.39, m, 1H, H3′; 3.99, CH2IP; 3.90 – 3.84, m, 2H, CH2IP + H4′;
3.62 – 3.56, 1H, H5′ or H5″; 3.54 – 3.48, m, 1H, H5″ or H5′; 2.65, ddd, 1H, J = 13.3, 6.8,
5.9 Hz, H2″; 2.31, ddd, J = 13.3, 6.8, 3.3 Hz, 1H, H2′; 1.67, CH3IP ppm. 13C (125 MHz,
DMSO-d6) 156.3, C6; 146.7, C4; 146.6, 1JC-H=207.0 Hz, C2; 141.2, C3IP
139.1, 1JC-H=214.5 Hz, C8; 123.5, C5; 114.1, 1JC-H=156.0 Hz, C=CH2IP; 88.1, C4′;
83.5, 1JC-H=164.5 Hz, C1′; 70.8, C3′; 61.8, C5′; 60.4, CH2IP; 58.4, C2IP; 39.9, C2′;
20.7, 1JC-H=127.0 Hz, CH3IP ppm.
Ade-1—1H (500 MHz, DMSO-d6) 8.32, s, 1H, H8; 8.18, s, 1H, H2; 6.74, s, 2H, N6H; 5.33,
bs, 1H, 1-OHIP; 5.28, dd, 1H, J = 7.5, 3.5 Hz, H2IP; 5.02, m, 1H, C=CH2IP; 4.75, m, 1H,
C=CH2IP; 4.08, ddd, 1H, J = 10.9, 7.5, 2.9 Hz, CH2IP; 3.97, m, 1H, CH2IP; 1.65, CH3IP
ppm. 13C (125 MHz, DMSO-d6) 159.6, C4; 152.0, 1JC-H=198.0 Hz, C2; 151.7, C6;
144.5, 1JC-H=210.5 Hz, C8; 142.1, C3IP; 113.9, C=CH2IP; 111.6, C5; 63.0, C2IP;
19.9, 1JC-H=127.0 Hz, CH3IP ppm.
RESULTS
Identification and Characterization of Adducts Resulting from the Reaction of Racemic
Isoprene Monoepoxides with dAdo
General considerations in structural assignments—In addition to regioisomers
resulting from addition of dAdo at the internal and terminal oxirane carbons of the IP
oxides, diastereomers of the N9-deoxyribosyl adducts and racemic mixtures of
deglycosylated bases are possible as a result of the asymmetry at the internal sp3 carbon of
the side-chain derived from ring-opening of an isoprene epoxide.
As described below, the availability of the pure S-enantiomers of IP-1,2-O and IP-3,4-O
allowed a number of adducts to be characterized to the level of absolute configuration, under
the assumption that opening of the oxirane occurs predominantly via an SN2-mechanism
with inversion of configuration at the chiral center. Products were tentatively identified as
dAdo or N1-dIno adducts by comparison of UV spectra acquired by diode array scans with
spectra of structurally similar adducts (37;44–46). The UV spectra of the N1-dIno adducts of
isoprene monoepoxides have a maximum at 250 nm with a characteristic shoulder at ~273
nm (Figure 3a), while a shoulder is absent from the spectra of the N1-and N6-dAdo adducts
(Figure 3b, spectra not shown for N1-dAdo adducts), which are characterized by
symmetrical maxima at 260 and 265–270 nm, respectively. Confirmation of assignments
based on UV-vis spectra was derived from comparison of chromatograms of dAdo-isoprene
monoepoxide reaction mixtures with those of dIno-isoprene monoepoxide reaction mixtures
(Figures 2 & S1).
Support for the assignments of adducts as dAdo or dIno adducts was also provided by LC-
ESI-MS/MS analysis of the reaction mixtures in full scan mode with simultaneous DAD
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detection using chromatographic conditions identical to those of the analytical HPLC-DAD
analysis. Isoprene-derived dAdo and dIno adducts fragment similarly to other DNA adducts
and nucleosides (47): the full scan mass spectra of dAdo adducts were characterized by a
series of ions at m/z 336 (MH+), 220 ([MH – dR]+), 136 ([MH – dR – C5H9O]+), and the
dIno adduct mass spectra by ions at m/z 337 (MH+), 221 ([MH – dR]+), 137 ([MH – dR –
C5H9O]+) (Table 1). Furthermore, it was shown that adducts derived by attack either on the
external or internal oxirane carbon of isoprene monoepoxides have distinctly different
fragmentation patterns in the MS/MS of the ion corresponding to [MH – dR]+ (Table 1,
Figures 4 and S2 & S3, Schemes S1 & S2).
Both 1H NMR and 2D homo- and heteronuclear shift correlation spectra completed the
structural assignments. A number of features of the NMR spectra were generally applicable
in interpreting NMR data. Although diastereomers are, in principle, different compounds -
and several of the diastereomeric adducts were completely resolved by HPLC - the proton
and carbon shifts of the diastereomers were virtually identical and differences in 1H and 13C
chemical shifts could be resolved for only a few signals. Shift assignments of carbon and
proton signals of the deoxyribose (dR) moiety could be readily made on the basis of
comparison with published coupling patterns and hyperfine shifts in the 1H NMR spectra
(48) and C,H coupling in the single- and multiple-bond shift correlation spectra (HSQC and
HMBC, respectively). The proton and carbon signals of the base moieties of adducts were
similarly assigned (complete 2D spectra are provided in Figures S4 – S21). In all HMBC
spectra, unsuppressed one-bond couplings 1JC,H were observed at C8 and the isoprenyl side-
chain methyl group (the term ‘isoprenyl’ refers to the C5 unit derived from ring-opening of
an isoprene epoxide). Unsuppressed one-bond couplings at purine C2 and deoxyribose C1′
were also observed for most adducts. The magnitudes of the one-bond couplings were
uniformly in accord with expectation (49), and useful in supporting signal assignments.
Two- and three-bond couplings were observed between the isoprenyl methyl protons and the
methyl-substituted and adjacent isoprenyl backbone carbons, providing unequivocal
assignment of three of the four isoprenyl side-chain carbons. With the exception of product
Ade-1, the deglycosylated N7 adduct, straightforward assignment of the remaining isoprenyl
carbon signal was made from HSQC and HMBC data.
As indicated in the structural diagrams, the numbering convention applied to the isoprenyl
side-chain of adducts is assignment of position 1 to the carbon closest to the point of
attachment to the base. As a result, the isoprenyl backbone carbons are renumbered in the
adducts of IP-3,4-O. Assignment of the proton and carbon signals of the isoprenyl side-
chains allowed determination of the points of attachment on both the isoprenyl side-chain
and base. In the case of products dIno-2, dIno-5, dAdo-7, dAdo-2, and dAdo-3, the
regiochemistry of addition could be determined unambiguously through connectivity
observed between the side-chain and the base in the heteronuclear shift correlation spectra.
For the remaining adducts, substituent effects on 13C chemical shifts of the IP side-chain
carbons were important in rigorous structural assignments. Nucleophilic attack at the
terminal oxirane carbon of IP-3,4-O will result in an aminohydrin adduct in which the
internal carbon (C2IP) bears both hydroxyl and vinyl substituents, resulting in a strong
downfield carbon shift for this carbon atom (50). For adducts at the terminal carbon, C2IP is
therefore expected to show a substantial downfield shift relative to C1IP. By contrast, the
aminohydrin from attack at the internal oxirane carbon bears the hydroxyl substituent on
C1IP and the shifts of C1IP and C2IP are nearly identical. This behavior has been reported for
the isoprene adducts of Gua (35), in which addition at the terminal oxirane carbon results in
a shift of C2IP >10 ppm downfield relative to C1IP, while the separation of signals is < 3
ppm for adducts at the internal carbon. The shifts of the terminal (C4IP) and internal (C3IP)
vinylic carbons also behave in accord with expectation, with the internal vinyl carbon
signals appearing >20 ppm downfield of the terminal vinyl carbon signals. The HMBC and
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HSQC spectra recorded for the dIno-5 adduct in Figure 5 illustrate the NMR features that
were helpful in making structural assignments.
Adducts of IP-1,2-O: The major adducts of racemic-IP-1,2-O (rac-IP-1,2-O) were two sets
of diastereomers formed by addition of the exocyclic amino group of dAdo at the terminal
(C1) and internal (C2) oxirane carbons (the numbering of the isoprene side-chain does not
change for IP-1,2-O adducts). Adducts were collected by semipreparative HPLC in three
major peaks (dAdo-1, dAdo-2, dAdo-3), having UV-vis spectra characteristic of N6-dAdo
adducts (Figure 3b). On an analytical HPLC column, dAdo-1 appeared to contain
unresolved components (Figure 1a).
Analysis of the reaction mixture by LC-MS yielded mass spectra consistent with dAdo
adducts (Figure 4) for all three peaks. MS/MS of the ion at m/z 220, present in all three mass
spectra, showed loss of H2O in the case of the dAdo-1 mixture and loss of the isoprenyl
moiety for dAdo-2 and dAdo-3 based on the resulting fragment ions m/z 202 and m/z 136,
respectively (Figure 4). The fragmentation patterns are in accord with diastereomeric pairs
from two regioisomers. The transition state stabilization by allylic resonance should favor
loss of H2O from the secondary alcohols arising via addition at the terminal oxirane carbon,
while loss of the isoprenyl moiety by breaking of the bond to the purine would be favored
from adducts derived by attack at the internal oxirane carbon (Scheme S1). Thus, dAdo-1 is
comprised of partially resolved terminal oxirane adducts and dAdo-2 and -3 represent
adducts at internal oxirane carbons.
Mild acid hydrolysis of the dAdo-rac-IP-1,2-O reaction mixture gave two major product
peaks that corresponded in their fragmentation patterns of the MS/MS of the ion at m/z 220
to those of the regioisomeric pairs of N6-dAdo adducts, which must therefore be racemic
mixtures of the deglycosylated adducts at terminal and internal oxirane carbons, respectively
(Figure 1b). Also consistent with the assignment of the dominant products as two sets of
diastereomers, are the observations that the major dAdo-S-IP-1,2-O adducts (Figure S22) co-
chromatograph with dAdo-1, and dAdo-2 and have identical ESI-MS/MS fragmentation
patterns. On this basis, dAdo-2 and dAdo-3 can be assigned to the diastereomeric adducts at
the internal oxirane carbon of the R-, and S-IP-1,2-O enantiomers, respectively, and dAdo-1
to an unresolved mixture of diastereomeric adducts at the terminal carbon.
The 1H NMR spectra establish that dAdo-1, dAdo-2 and dAdo-3 are adducts at the
exocyclic amino group of dAdo on the basis of one-proton singlets at hyperfine shifts
expected for N6H, 7.16 ppm for dAdo-1 (Figures S4, S5) and 6.79 ppm for dAdo-2 and
dAdo-3 and confirmed as amino protons by the absence of C,H correlations for these signals
in the HSQC spectra (Figures S6, S7). (1H and 13C chemical shifts of dAdo-2 and dAdo-3
were identical and the fractions were combined and analyzed as a mixture for 2D NMR to
improve the quality of the spectra.) The suggestion that dAdo-1 is probably a mixture of
diastereomers, is supported by partial resolution of two H1′ signals in the 1H NMR spectrum
(Figures S4, S5). Resolution of two sets of diastereotopic methylene signals at C1IP,
adjacent to the stereogenic center, which are also expected to be highly sensitive to
structural differences induced by differing configurations at C1′ and C2IP, was precluded by
overlap with H5′,H5″ signals. The 13C and the remaining 1H shifts of the diastereomers
were identical. Although no C,H correlations could be detected between the isoprenyl side-
chain and the purine base in the HMBC spectrum, the assignment of the dAdo-1 mixture as
regioisomers from addition at the terminal oxirane carbon of IP-1,2-O is established by the
large chemical shift difference between C1IP and C2IP. The signal corresponding to C1IP at
49.4 ppm is established by a cross peak with the isoprenyl methyl protons at 1.18 ppm in the
HMBC spectrum. The signal for C2IP is identified at 72.4 ppm by cross peaks with H3IP at
5.93 ppm and the terminal methylene protons at 4.98 and 5.24 ppm. The C1IP – C2IP shift
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difference of 23.0 ppm for dAdo-1 compared to 9.0 ppm for dAdo-2 and dAdo-3 (vide
infra) is consistent with the assignment of dAdo-1 as the adduct at the terminal oxirane
carbon. dAdo-2/dAdo-3 are unequivocally assigned as adducts at the internal oxirane
carbon by the HMBC spectrum: there are cross peaks between N6H and both the isoprenyl
methyl carbon at 21.6 ppm and a carbon at 58.9 ppm, assigned to methyl-substituted C2IP
based on 2-bond coupling with the isoprenyl methyl protons and no attached proton,
indicated by the absence of a C,H correlation in the HSQC spectrum. In the HSQC
spectrum, C1IP appears at 67.9 ppm, and as discussed above, the C1IP – C2IP shift difference
of 9 ppm relative to 23.0 ppm for dAdo-1 is in accord with this assignment. Thus, dAdo-2
can be characterized as the N6-2-R- and dAdo-3 as the N6-2-S-isopropenyl adducts of dAdo.
See Table 1 for complete structural assignments.
Adducts of IP-3,4-O: HPLC separation of the dAdo-rac-IP-3,4-O reaction mixture yielded
a total of nine products in sufficient quantity to characterize by UV-vis and full scan mass
spectra (Figure 2a). In this manner, three major products could be identified as dAdo
adducts dAdo-6, dAdo-7, dAdo-8 and four minor products as dIno adducts dIno-2, dIno-3,
dIno-4, dIno-5. The identity of the dIno adducts was confirmed by co-chromatography with
reaction products of dIno with IP-3,4-O (Figure S1a). The retention times of two additional
products were shorter than the dAdo and dIno adducts and did not change following mild
acid hydrolysis of the reaction mixture, implying that they are deglycosylated adducts
(Figure 2b). This conclusion was supported by full scan mass spectra which contained no
ions corresponding to adducted nucleosides and by UV-vis spectra, which were similar to
those reported for N3- and N7 adducts of Ade with butadiene monoepoxide (37).
dAdo adducts—In the MS/MS of the ion at m/z 220, dAdo-8 readily loses water and 2-
methylpropenol based on the major product ions m/z 202 and m/z 148, respectively (Figure
S2A). In the MS/MS of m/z 220 from dAdo-6 and dAdo-7 loss of the isoprenyl side-chain
along with loss of H2O accounted for the product ions m/z 136 and m/z 136 (Figure S2B).
Loss of 2-methylpropenol unit could only occur from the adduct at the terminal position of
IP-3,4-O, while formaldehyde might be expected from the adduct at the internal carbon. The
mass spectra therefore support dAdo-8 as a mixture of diastereomers at the terminal carbon
and dAdo-6 and dAdo-7 as adducts at the internal carbon of IP-3,4-O.
As expected for pairs of diastereomers, mild acid hydrolysis of the reaction mixture from
dAdo and rac-IP-3,4-O yielded two major deglycosylation products (Figure 2b), which
corresponded in their fragmentation patterns of the MS/MS of the ion at m/z 220 to those of
the regioisomeric pair of N6-dAdo adducts. Major products of the reaction of dAdo with S-
IP-3,4-O co-chromatographed with dAdo-7 and dAdo-8. Under the assumption of an SN2
reaction, the adducts at the internal oxirane carbon, dAdo-7 and dAdo-6 can be assigned R
and S configurations, respectively, at C2IP. The contribution to the dAdo-8 mixture from
addition to the terminal oxirane carbon of S-IP-3,4-O has S configuration at C2IP (Figure
S21).
In 1H NMR spectra of the three fractions, one-proton signals corresponding to N6H indicate
attachment of the isoprenyl chain to dAdo at the exocyclic amino group. The identity of N6H
was confirmed by absence of a cross peak with carbon in the HSQC spectra. The 1H shifts
of dAdo-6 and dAdo-7 are virtually identical (Figures S8 – S12). The quantity of Ado-6
collected was significantly smaller than dAdo-7, precluding the establishment of
connectivity between the C4 chain and the base in the C,H shift correlation experiments.
The observable carbon shifts of dAdo-6 were identical to the corresponding signals of
dAdo-7. Based on the similarity of the 1H and 13C shifts, dAdo-6 and dAdo-7 are
diastereomers, and assignment of the regiochemistry of addition described below for
dAdo-7 applies to both products.
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The shifts of deoxyribose C5′ and the terminal sp3 methylene (C1IP) of the isoprenyl side-
chain (61.5 ppm) are identical, but are assigned by resolution of the proton signals in the
HSQC spectrum (Figure S11). The internal isoprenyl sp3 carbon C2IPsignal can be assigned
at 56.6 ppm by virtue of cross peaks with the isoprenyl methyl protons at 1.76 ppm and
vinyl methylene C4H2IP at 4.79 ppm. The shift difference of 4.9 ppm between C1IP and
C2IP suggests addition at the internal oxirane carbon, which is consistent with the
appearance of N6H as a doublet, coupling with H2IP. The absence of a cross peak for
expected 2-bond connectivity between C2IP and N6H can probably be ascribed to
broadening of this signal. However, a cross peak between H2IP and N6H in the DFQC
spectrum (Figure S12) confirms the N6H-C2IP coupling and the structural assignment of
addition at the internal oxirane carbon. In the HPLC trace of the products from reaction of
3S-IP-3,4-O with dAdo one of the major products co-elutes with dAdo-7. Taking into
account that dAdo-7 and dAdo-6 are diastereomers and assuming that oxirane ring opening
occurs with inversion of configuration at C2IP, dAdo-7 is assigned as the 2R diastereomer
and dAdo-6 as the 2S diastereomer from adduct formation at the internal oxirane carbon,
consistent with the conclusion above based on comparison of the HPLC traces obtained
from the reaction of dAdo with S-IP-3,4-O and with rac–IP-3,4-O.
In the HMBC spectrum of dAdo-8 (Figure S13) from the reaction of rac-IP-3,4-O,
connectivity was not observed between the isoprenyl side-chain and the base. This may be a
consequence of broadening of H2, N6H, H2IP and the diastereotopic C1IP methylene signals
as a result of imino-amino tautomerism of the purine or rotational isomerization about the
N6-isoprenyl bond on a time scale approaching the NMR time frame. Additionally, while
dAdo-8 from rac-IP-3,4-O is expected to be a mixture of diastereomers, neither the proton
nor carbon signals at the 1′ and 2IPpositions were resolved into multiple signals, although
these should be most sensitive to the differences in configuration at the stereogenic centers.
In the HSQC spectrum (Figure S14), C1IP and C2IP appear at 44.5 and 72.6 ppm,
respectively. The separation of 28.1 ppm between C1IP and C2IP is consistent with
attachment at the terminal oxirane carbon, and is also in accord with the loss of water and 2-
methylpropenol in the MS2 of the deglycosylated product ion. An adduct of S-IP-3,4-O and
dAdo co-chromatographs with dAdo-8, indicating that the 3S diastereomer contributes to
dAdo-8. Based on the observation that the NMR data do not appear to distinguish between
diastereomers of dAdo adducts in a definitive manner (vide infra), dAdo-8 is assigned as a
mixture of the diastereomeric adducts at the terminal oxirane carbon. See Table 1 for
complete structural assignments.
dIno adducts—dIno-2, dIno-3, dIno-4, and dIno-5, were identified as dIno adducts by
exact mass measurements of the protonated molecules, full scan ESI-MS and UV-vis.
Definitive assignment as dIno adducts was further confirmed by co-chromatography with
the reaction products of dIno with rac-IP-3,4-O (Figures 2a, S1a). Comparison of HPLC
traces of the reaction mixtures from dAdo and dIno with rac- and S-IP-3,4-O indicated that
dIno-2 and dIno-4 were adducts of S-IP-3,4-O (Figures S23, S24). The pairs dIno-2/dIno-3
and dIno-4/dIno-5 displayed distinct differences in abundance of ESI-MS/MS fragments of
m/z 221 and could therefore be assigned as diastereomeric pairs of regioisomeric adducts.
The major product ion of dIno-2/dIno-3 (m/z 203) resulted from loss of H2O, while dIno-4
and dIno-5 fragmented predominantly to m/z 137 through loss of the isoprenyl side-chain.
In addition to the N6-Ade adducts described above, mild acid hydrolysis of the reaction
mixture of dAdo and rac-IP-3,4-O yielded a pair of hypoxanthine adducts (deglycosylated
dIno adducts) with retention times similar to those observed after mild acid hydrolysis with
rac-IP-3,4-O adducts of dIno (Figure 2b, Figure S1b). Furthermore, the two hypoxanthine
adducts corresponded in their MS/MS fragmentation patterns of the ion at m/z 221 to those
of the regioisomeric pairs of the dIno adducts. Although only dIno-2 and dIno-5 were
collected in sufficient quantity for characterization by NMR (Figures S15 – S18), the
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relation of dIno-2 and dIno-3 as 2IP-S- and 2IP-R diastereomers from addition at the
terminal oxirane carbon and dIno-4 and dIno-5 as the 2IP-R- and 2IP-S- diastereomers from
addition at the internal oxirane carbon allowed complete structural assignment of all four
dIno adducts. It is worthy of comment that reaction of S-IP-3,4-O with dAdo yielded a the
single predominant diastereomer, dIno-4, identified (vide infra) as the adduct at the internal
oxirane carbon. Similarly, the reaction of S-IP-3,4-O yielded dIno-2 and dIno-4 as the
predominant diastereomers. The absence of dIno-3 and dIno-5 as significant products
indicates little or no racemization during substitution at either oxirane carbon, implying that
an SN2 reaction mechanism predominates. If reaction at the internal oxirane carbon had
proceeded by an SN1 mechanism (36) via an intermediate allylic cation, this should have
resulted in racemization at C2IP to yield ~ equal proportions of adducts at the internal
oxirane carbon, dIno-4 and dIno-5.
The absence of imino NH signals in the 1H NMR spectrum supported substitution at N1.
dIno-2 was assigned as the N1 adduct at the terminal oxirane carbon based on the following
evidence. The two sp3 carbon signals of the isoprenyl side-chain appear at 49.9 and 71.3
ppm. The ~21 ppm separation is consistent with attachment at the terminal oxirane carbon,
which is confirmed by a cross peak in the HMBC spectrum between the carbon signal at
49.9 ppm and H2 of dIno, strong 3-bond coupling between the diastereotopic methylene
proton signal at 3.76 ppm and C2 and C6 of dIno and weak 4-bond coupling between H2IP
and dIno C2 and C6. Consistent with assignment of dIno-5 as the product of addition to the
internal oxirane carbon, the two sp3 carbon signals of the isoprene side-chain appear at 58.4
and 60.4 ppm, separated by only 2 ppm. Cross peaks in the HMBC spectrum between H2IP
at 5.37 ppm and C2 and C6 of dIno at 146.6 and 156.3 ppm, respectively, confirm C2IP as
the point of attachment, with additional support from observation of the corresponding cross
peak between H2 of dIno at 8.23 ppm and C2IP at 58.4 ppm (Figure S17). See Table 1 for
complete structural assignments.
N7-Ade adduct—Of the two product peaks tentatively identified as N3- or N7-Ade
adducts based on UV-vis and mass spectra, only Ade-1 (see Figure 3c for UV spectra,) was
collected in sufficient quantity for NMR characterization (Figures S19 – S21), although the
set of heteronuclear shift correlations observed was incomplete. The absence of C,H
correlations of the diastereotopic methylene protons allowed identification of only three
isoprenyl backbone carbon signals. In the 1H NMR spectrum, a two-proton singlet at 6.74
ppm with no C,H correlation in the HSQC spectrum and a cross peak with C5 in the HMBC
spectrum can be assigned to the exocyclic amino protons, ruling out attachment at N6. A
carbon at 63.0 ppm having cross peaks with the terminal vinyl methylene protons at 4.08
and 3.97 ppm and the isoprenyl methyl protons at 1.65 ppm can be assigned to C2IP. The
shift suggests that C2IP is the point of attachment of the base to the isoprenyl side-chain,
since a shift of ~ 70 ppm would be predicted for C2IP if the point of attachment were at
C1IP. The attachment of the isoprenyl side-chain at C2IP is confirmed by the HMBC
spectrum in which H2IP has a cross peak with C8 of Ade. The NOESY spectrum (Figure
S21) demonstrates N7 rather than N3 as the site of attachment to the base. NOESY cross
peaks are observed between H8 and the isoprenyl methyl, one of the diastereotopic
methylene protons, one of the terminal vinyl methylene protons and H2IP, which would not
be possible for an N3 adduct. Based on the NMR analysis, Ade-1 is assigned as the racemic
N7-Ade adduct from attack at the internal oxirane carbon of IP-3,4-O. See Table 1 for
complete structural assignment.
DISCUSSION
Isoprene is carcinogenic in mice and rats. Its mode of action is thought to be via metabolic
activation and formation of pro-mutagenic DNA adducts that subsequently result in
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mutagenesis and tumorigenesis. We have previously reported formation of guanine adducts
by isoprene monoepoxides (35). However, isoprene-induced tumors in mice show unique
point mutations (A→T transversions) in the K-ras protooncogene (19;20). Consequently we
extended our investigation to the reaction of the two monoepoxides of isoprene with 2′-
deoxyadenosine. We present here for the first time the characterization of adducts formed by
isoprene monoepoxides with dAdo under physiological conditions. Major stable adducts of
each monoepoxide were identified by HPLC, UV-Spectrometry and LC-MS and
characterized by 1H and 1H,13C HSQC and HMBC NMR experiments.
We demonstrated formation of regioisomeric N6-dAdo adducts with both monoepoxides and
formation of N1-dIno adducts with IP-3,4-O. In addition the reaction with IP-3,4-O also
formed significant amounts of an N7-Ade adduct, stemming from deglycosylation of the
unstable N7-dAdo adduct (51). Difficulties in characterizing the minor products of IP-1,2-O
were due to its tendency for rapid hydrolysis in aqueous solution (29;52). This instability of
IP-1,2-O lies in the direct attachment of the methyl group to the oxirane ring enhancing SN1
attack at the internal oxirane carbon by a nucleophile such as water (52). Therefore,
reactions with IP-1,2-O yielded smaller amounts of adducts compared to IP-3,4-O.
Besides N6-dAdo and N1-dIno adducts, N1-dAdo were expected to form under the study
conditions. It should be noted however, that we did not attempt to identify N1-dAdo
adducts, because they readily rearrange or deaminate to the corresponding stable N6-dAo
and N1-dIno adducts, respectively (38;40). In biomarker studies, stable adducts are essential
to increase reproducibility and N1-Ade adducts have been converted to N6-adducts for
analysis (39).
Adducts that we could tentatively identify as N1-dAdo adducts based on retention times that
were similar to dAdo, and their UV spectra (λmax = 260) (44–46), were not detectable when
the incubation time was extended from 1 day to 3 days. Therefore, to increase yields of the
stable adducts, dAdo was incubated for 3 days with each monoepoxide. Structural
assignments made by UV and MS were confirmed by NMR. Diastereomeric assignments
were made based on the fact that adduct formation by a SN2 mechanism on the internal
(stereogenic) oxirane carbon leads to a inversion of configuration, whereas adduct formation
by SN2 mechanism on the terminal oxirane carbon does not affect configuration on the
stereogenic (internal) oxirane carbon. Steric effects favor SN2 reaction at the terminal
carbon, whereas substituents on the internal carbon that can stabilize positive charge favor
reaction at the internal carbon by either SN1 or SN2 mechanisms (36). The assignment of a
SN2 mechanism to adducts at the internal oxirane carbons of the isoprene oxides is based on
the observation that pure S-IP-1,2-O and S-IP-3,4-O yielded predominantly single
diastereomers (dAdo-2 and dAdo-7, dIno-2 and dIno-4, respectively) rather than
diastereomeric mixtures expected to result from SN1 reaction. The requirement for a
stereoselective process thus suggests adduct formation predominantly through a SN2 rather
than a SN1 pathway, although adduct formation at the internal oxirane carbon of the IP-1,2-
O is sterically hindered and has been proposed to occur through a SN1 (or SN1-like)
mechanism, as also suggested for N7-guanine adducts of isoprene monoepoxides (35).
Whereas simple mono-alkyl epoxides (e,g, methyloxirane) react with nucleophiles
predominantly at the less hindered terminal carbon by a SN2 mechanism, the situation with
IP-1,2-O is more complex because of stereoelectronic effects from the ethenyl group, which
may facilitate an internal SN2 or SN2-like pathway (53). The precise mechanistic details of
the reactions described at the internal carbon of IP-1,2-O requires further study. The
designation SN2 in this paper should be taken primarily as a description of the established
stereochemical outcome for the adducts characterized.
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While exact quantification is not possible under the experimental conditions of the present
study, comparing UV-peak heights of the respective regioisomers suggests a greater
formation of N6-dAdo adducts with the terminal oxirane carbon of either monoepoxide
compared to the respective internal oxirane carbon. Since adducts on N6-dAdo can
theoretically originate either from Dimroth rearrangement of N1-dAdo adducts or via direct
alkylation, in our study it was not possible to determine the reactivity of the internal or
external oxirane carbons of the isoprene monoepoxides towards the N6- (or N1-) position.
Studies with epoxides containing substituents capable of delocalizing positive charge by
conjugation, such as styrene oxide and butadiene monoepoxide, show that direct alkylation
of the N6-position of adenosine occurs mainly on the internal oxirane carbon, predominantly
by a SN1 mechanism (as reviewed in 36). In contrast, it was demonstrated that N6- dAdo
adducts on the terminal oxirane carbon of styrene oxide were exclusively formed by
Dimroth rearrangement of N1-dAdo adducts (40;54).
Incubation of dAdo with pure S-IP-1,2-O and S-IP-3,4-O resulted in formation of
predominant diastereomeric N6-dAdo adducts from reactions at the internal oxirane carbon
(dAdo-2 and dAdo-7, respectively (Figure S22 and S23). As discussed above, this result
does not support adduct formation via a SN1 reaction but rather indicates that the adducts are
mainly formed via SN2 mechanism, with IP-3,4-O as well as with IP-1,2-O. Our study was
not designed to enable us to make a distinction between N6-dAdo adducts at the internal
oxirane carbon of isoprene monoepoxides originating from Dimroth rearrangement of an
N1-dAdo adduct or direct alkylation of N6. It cannot be assumed that the proposed reaction
mechanism and the results with butadiene monoepoxide and styrene oxide as described
above are predictive of the origin of the detected isoprene monoepoxide N6-dAdo adducts.
In contrast to the diastereomeric adducts formed from reaction at the internal oxirane
carbon, the R- and S-diastereomers of adducts at the terminal oxirane carbon could not be
chromatographically resolved for either of the isoprene monoepoxides.
Due to the small quantities of potential N1-dIno adducts detected after reaction of dAdo
with IP-1,2-O, these were not further investigated. Reaction of IP-3,4-O at N1 of dAdo and
subsequent deamination preferentially produced internal oxirane adducts judging by UV
peak heights of the diastereomeric adduct pairs dIno-2 and -3 and dIno-4 and -5. This
observation is in accord with results of other investigators. Qian and Dipple (54) reported
that deamination of N1-adenosine adducts on the terminal oxirane carbon of styrene oxide
was very slow in comparison to deamination of adducts on the internal oxirane carbon. It
was suggested that deamination occurs by a mechanism in which the hydroxyl group of the
side-chain displaces the exocyclic (N6) amino group intramolecularly to form an
oxazolinium ring system. This reactive intermediate could then be opened by water,
facilitating a nucleophilic attack at the C6- position of the purine. The observed higher
deamination rate for the styrene oxide adduct on the internal oxirane carbon was thought to
be due to the higher nucleophilicity of its hydroxyl-group relative to the hydroxyl-group in
closer proximity to the phenyl ring (54). Preliminary results from reactions of isoprene
monoepoxides with ssDNA suggest that the proportion of deaminated products (N1-
hypoxanthine adducts) increased for adducts on the terminal oxirane carbon when dAdo was
incorporated into DNA and implied that DNA structure favors this reaction (data not
shown), which has been reported previously (40). In contrast to the deamination of N1-dAdo
adducts (Figure 2a), direct reaction of N1-dIno with IP-3,4-O seemed to occur preferentially
on the terminal oxirane carbon (Figure S1a). Our experiments were not designed to
determine whether the differences in adduct yields are due to selective deamination of N1
adducts of dAdo adducts at the internal oxirane carbon, or to a difference in the reactivity of
the oxirane carbons towards N1 of dAdo relative to N1 of dIno. Preferential reaction with
the terminal oxirane carbon of IP-3,4-O with the endocyclic N1 nitrogen of dIno is in
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contrast to our findings for the reaction of IP-3,4-O with N7 of dGua, where adducts were
formed preferentially on the internal oxirane carbon (35). As observed above, it is also
noteworthy that the adduct at the internal oxirane carbon of IP-3,4-O appears to form via a
SN2 substitution, in contrast to reports of an SN1 substitution for butadiene monoepoxide
and styrene oxide (36).
Although the N3 position of Ade has been reported to be a major alkylation site in DNA,
steric hindrance due to intra- or intermolecular hydrogen-bonding of the N3-position is
thought to hamper adduct formation at this position in the free nucleosides (36;55).
Accordingly, N3-Ade adducts were not identified in the present study. It is likely that they
were formed in insufficient amounts for collection and characterization. A product that
eluted close to a peak suspected to be an N3-Ade adduct based on its UV spectrum was
unequivocally identified as the N7-Ade adduct on the internal oxirane carbon of IP-3,4-O
(Ade-1). Both Ade-1 and the unidentified product, were detected in the chromatograms of
the reaction mixture of IP-3,4-O with dAdo before and after hydrolysis.
N1-Deoxyinosine adducts have been shown to be highly mutagenic in site-directed
mutagenesis studies. The mutagenicity is believed to reside in the structural similarity
between inosine and guanosine. Inosine or its corresponding base, hypoxanthine, pair
predominantly with cytosine and to a smaller extent with the other bases in the order I-C > I-
A > I-G = I-T (56;57). Therefore, the presence of dIno, instead of dAdo in DNA, has the
potential to lead to the incorporation of an incorrect base. Although an adduct on the N1-
position could block Watson-Crick base pairing, N1-dIno adducts of butadiene epoxides
have been demonstrated to be easily bypassed during replication and lead to mutations in in
vitro experiments in Escherichia coli and mammalian cells, with A → G transitions being
the predominant mutations (42;58). Additionally, as discussed above, the extent of the
deamination reaction of N1-Ade adducts leading to these adducts is dependent on the
specific adduct stereo- and regio-chemistry (54). The formation of N1-Ade or N1-Ado
adducts has been well established in vitro (45;46). Furthermore, one study in workers
exposed to butadiene detected N1-Ade adducts by 32P-postlabeling (39). N1-hypoxanthine
adducts were not detected in vivo in one study in mice and rats exposed to 625 ppm
butadiene for 10 days (Boysen, unpublished results).
The mutational potential of N6-Ade adducts seems to be rather low and largely dependent on
the bulkiness of the adduct and its stereochemical conformation (59;60). However, these
adducts could be used as stable biomarkers of internal exposure (36).
Similar to N3-dAdo or N7-dGuo adducts, N7 adducts of dAdo with IP-3,4-O readily
deglycosylated, giving rise to abasic sites in DNA. Although abasic sites can be repaired and
therefore might not have a high potential to lead to mutations, the base adducts might be
used as biomarkers of exposure. For example, N7-Gua adducts can be detected in urine (51).
In conclusion, this is the first study to demonstrate formation of adducts of isoprene
monoepoxides with dAdo. Both isoprene monoepoxides formed N6-dAdo and/or N1-dIno
adducts on the external as well as internal oxirane carbons. Furthermore, we identified an
N7-Ade adduct at the internal oxirane carbon of IP-3,4-O. Describing the exact structure of
adducts formed by isoprene monoepoxides with deoxynucleosides and subsequently those
formed with DNA can serve as an initial step toward evaluating their potential for mutation
or for use as biomarkers of isoprene metabolism and internal exposure.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HPLC/DAD analysis of the reaction mixtures of IP-1,2-O with dAdo before (a) and after
mild acid hydrolysis (b). Separation on a 4.6 × 250 mm C18 Aquasil column, 1 mL/min,
gradient program 1.
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HPLC/DAD analysis of the reaction mixtures of IP-3,4-O with dAdo before (a) and after
mild acid hydrolysis (b). Separation on a 4.6 × 250 mm C18 Aquasil column, 1 mL/min,
gradient program 1.
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Representative UV-Spectra for (a) N1-dIno adducts, (b) N6-dAde adducts, and (c) N7-Ade
adducts.
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Representative MS spectra for terminal (C1) and internal (C2) N6-dAdo adducts derived
from reaction with IP-1,2-O. Shown are the full scan m/z 100 to 400 (top spectrum), the
product ion spectrum from ions m/z 336 (middle) and m/z 220 (bottom) of dAdo-1 (A) and
dAdo-2 (B), respectively.
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HMBC (A) and HSQC (B) spectra of the N1-dIno adduct of IP-3,4-O at the internal oxirane
carbon (dIno-5). Carbon and proton signal assignments are indicated on the marginal traces.
In the HMBC spectrum, unsuppressed 1-bond couplings are indicated by brackets. Key
features of the HMBC spectrum in establishing regiochemistry of addition are cross peaks
between H2IP of the isoprene side-chain and C2 and C6 of the purine nucleus and the 2 ppm
difference (not resolved) in chemical shifts between C1IP and C2IP. C,H connectivities are
indicated by solid lines. In the HSQC spectrum the C,H couplings of the isoprene vinyl
protons and methyl protons CH3IP (blue) are negatively phased.
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Proposed Adduct Formation of Isoprene Monoepoxides on dAdo: Example IP-1,2-O. *
Indicates a chiral center.
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Proposed Adduct Formation of Isoprene Monoepoxides on dAdo: Example IP-3,4-O. *
Indicates a chiral center.
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